Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
January 15, 2017
Red trays for people at nutritional risk have boosted patient satisfaction
Lesley Taylor
British Journal of Nursing (Mark Allen Publishing)
|
May 24, 2014
Using a soft-silicone dressing to treat moist desquamation
Ellen Trueman, Lesley Taylor
Immunologic Research
|
November 12, 2003
Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?
Kevan C Herold, Lesley Taylor
Clinical Pharmacokinetics
|
December 6, 2019
A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
Bola Tayo, Lesley Taylor, Farhad Sahebkar, et al.
Journal of Clinical Pharmacology
|
March 29, 2019
A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
Lesley Taylor, Julie Crockett, Bola Tayo, et al.
Journal of Clinical Pharmacology
|
July 12, 2020
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam
Kevan E VanLandingham, Julie Crockett, Lesley Taylor, et al.
BMC Cancer
|
January 3, 2024
Building pathology capacity in sub-Saharan Africa to improve breast cancer diagnosis and treatment: training laboratory technicians in high-quality manual immunohistochemistry
Linda Setiawan, Katy Graef, Dan Schmolze, et al.
CNS Drugs
|
March 5, 2019
Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry Gidal, Graham Blakey, et al.
CNS Drugs
|
October 31, 2018
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry Gidal, Graham Blakey, et al.
BMJ Open
|
October 25, 2011
A systematic mapping review of effective interventions for communicating with, supporting and providing information to parents of preterm infants
Jo Brett, Sophie Staniszewska, Mary Newburn, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
January 15, 2017
Red trays for people at nutritional risk have boosted patient satisfaction
Lesley Taylor
British Journal of Nursing (Mark Allen Publishing)
|
May 24, 2014
Using a soft-silicone dressing to treat moist desquamation
Ellen Trueman, Lesley Taylor
Immunologic Research
|
November 12, 2003
Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?
Kevan C Herold, Lesley Taylor
Clinical Pharmacokinetics
|
December 6, 2019
A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
Bola Tayo, Lesley Taylor, Farhad Sahebkar, et al.
Journal of Clinical Pharmacology
|
March 29, 2019
A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
Lesley Taylor, Julie Crockett, Bola Tayo, et al.
Journal of Clinical Pharmacology
|
July 12, 2020
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam
Kevan E VanLandingham, Julie Crockett, Lesley Taylor, et al.
BMC Cancer
|
January 3, 2024
Building pathology capacity in sub-Saharan Africa to improve breast cancer diagnosis and treatment: training laboratory technicians in high-quality manual immunohistochemistry
Linda Setiawan, Katy Graef, Dan Schmolze, et al.
CNS Drugs
|
March 5, 2019
Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry Gidal, Graham Blakey, et al.
CNS Drugs
|
October 31, 2018
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry Gidal, Graham Blakey, et al.
BMJ Open
|
October 25, 2011
A systematic mapping review of effective interventions for communicating with, supporting and providing information to parents of preterm infants
Jo Brett, Sophie Staniszewska, Mary Newburn, et al.
Page
of 4